ACHE and early-onset autosomal dominant Alzheimer disease: Acetyl cholinesterase (AChE) is an important therapeutic target to alleviate the deterioration of cholinergic neurons in the brain and the loss of neurotransmission, i.e., one of the major causes of Alzheimer’s disease.